![Roger W. Brimblecombe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger W. Brimblecombe
Director/Board Member at
2gether NHS Foundation Trust
Profile
Roger W.
Brimblecombe is currently a Director at 2gether NHS Foundation Trust.
He previously held Chairman positions at CeNeS Pharmaceuticals Plc, Vanguard Medica Plc, Oxford Asymmetry International Plc, EyePoint Pharmaceuticals, Inc., and Core Group Ltd. He was also a Director at Vertex Pharmaceuticals, Inc. for 17 years.
Brimblecombe has a graduate and doctorate degree from the University of Bristol.
Roger W. Brimblecombe active positions
| Companies | Position | Start |
|---|---|---|
2gether NHS Foundation Trust
 2gether NHS Foundation Trust Medical/Nursing ServicesHealth Services Provides health care services | Director/Board Member | 2009-05-26 |
Former positions of Roger W. Brimblecombe
| Companies | Position | End |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Director/Board Member | 2010-05-12 |
Tissue Science Laboratories Ltd.
 Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Develops and markets tissue implant products | Director/Board Member | 2008-04-30 |
| EYEPOINT, INC. | Chairman | 2006-12-31 |
Vertex Pharmaceuticals (Europe) Ltd.
 Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Director/Board Member | 2005-01-01 |
Oxford Asymmetry International Plc
 Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Chairman | 1999-12-31 |
Training of Roger W. Brimblecombe
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
CeNeS Pharmaceuticals Plc
 CeNeS Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the discovery and development of drugs | Health Technology |
Vanguard Medica Plc
 Vanguard Medica Plc Miscellaneous Commercial ServicesCommercial Services Provides research and development in neosciences | Commercial Services |
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Develops and markets tissue implant products | Health Technology |
Oxford Asymmetry International Plc
Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals (Europe) Ltd.
Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
Core Group Ltd.
 Core Group Ltd. Finance/Rental/LeasingFinance Provides construction equipment rental services | Finance |
Smithkline & French Laboratories US, Inc. | |
2gether NHS Foundation Trust
2gether NHS Foundation Trust Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
- Stock Market
- Insiders
- Roger W. Brimblecombe
